Clinical Application and Progress of Fecal Microbiota Transplantation in Liver Diseases: A Review

15Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The human gut harbors a dense and highly diverse microbiota of approximately 1,000 bacterial species. The interaction between the host and gut bacteria strongly influences human health. Numerous evidence suggest that intestinal flora imbalance is closely associated with the development and treatment of liver diseases, including acute liver injury and chronic liver diseases (cirrhosis, autoimmune liver disease, and fatty liver). Therefore, regulating the gut microbiota is expected to be a new method for the adjuvant treatment of liver diseases. Fecal microbiota transplantation (FMT) is defined as the transplantation of gut microbiota from healthy donors to sick patients via the upper or lower gastrointestinal route to restore the normal intestinal balance. In this study, we briefly review the current research on the gut microbiota and its link to liver diseases and then summarize the evidence to elucidate the clinical application and development of FMT in liver disease treatment.

Cite

CITATION STYLE

APA

Gu, X., Lu, Q., Zhang, C., Tang, Z., & Chu, L. (2021, November 1). Clinical Application and Progress of Fecal Microbiota Transplantation in Liver Diseases: A Review. Seminars in Liver Disease. Thieme Medical Publishers, Inc. https://doi.org/10.1055/s-0041-1732319

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free